NCT04795622View on ClinicalTrials.gov

Evaluation of the Effectiveness and Safety of the Ulthera® DeepSEE® System for Treating Skin Laxity in the Lower Face and Submentum

NACompletedINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

March 16, 2021

Primary Completion Date

January 18, 2022

Study Completion Date

May 17, 2022

Conditions
Improvement in Skin Laxity of the Lower Face and Submentum
Interventions
DEVICE

Ultherapy treatment

Focused ultrasound energy delivered below the surface of the skin

DEVICE

Untreated-control / delayed-treatment

Untreated-control, followed by Ultherapy treatment (focused ultrasound energy delivered below the surface of the skin)

Trial Locations (5)

100034

Peking University First Hospital, Merz Investigational Site #0860003, Beijing

100142

Air Force General Hospital, Merz Investigational Site #0860002, Beijing

100730

Beijing Hospital, Plastic Surgery, Merz Investigational Site #0860029, Beijing

200011

Shanghai 9th Hospital, Plastic Surgery, Merz Investigational Site #0860015, Shanghai

200040

Huashan Hospital Shanghai, Merz Investigational Site #0860004, Shanghai

All Listed Sponsors
collaborator

Ulthera, Inc

INDUSTRY

lead

Merz North America, Inc.

INDUSTRY

NCT04795622 - Evaluation of the Effectiveness and Safety of the Ulthera® DeepSEE® System for Treating Skin Laxity in the Lower Face and Submentum | Biotech Hunter | Biotech Hunter